SPONSOR
Tianjin Medical University Second Hospital
Total Trials
4
Recruiting
4
Phases
Phase 2, Phase 1, Phase 2
Conditions studied: Prostate Cancer (Adenocarcinoma)Prostate Cancer Metastatic Castration-ResistantProstate Adenocarcinoma With Neuroendocrine DifferentiationSolid TumorPrecision MedicineSolid Tumor, AdultNext-generation SequencingUpper Tract Urothelial CarcinomaLymph Node Dissection
NCT07179783 Phase 2
Recruiting
Sacituzumab Tirumotecan in Combination With Tagitanlimab in the Treatment of Aggressive Variant Prostate Cancer (AVPC) and Neuroendocrine Prostate Cancer (NEPC)
Prostate Cancer (Adenocarcinoma)
NCT06739395 Phase 2
Recruiting
Precision Medicine Trial Based on Molecular Matching Therapy for Patients With Standard Treatment Exhaustion
Solid Tumor
NCT06895733 Phase 1, Phase 2
Recruiting
Study of Pazopanib Combined With Palbociclib for Refractory Solid Tumors With Co-amplified in the 11q13(FGF3/4/19/CCND1)
Solid Tumor, Adult
NCT07321210
Recruiting
Radical Nephroureterectomy With vs Without Template Lymph Node Dissection in High-Risk Upper Tract Urothelial Carcinoma (T-LND UTUC): A Randomized Clinical Trial
Upper Tract Urothelial Carcinoma